velaglucerase alfa
velaglucerase alfa is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including VPRIV. Available dosage form: injection, powder, lyophilized, for solution.
Drug Details
- Generic Name
- velaglucerase alfa
- Brand Names
- VPRIV
- Application Number
- BLA022575
- Sponsor
- Takeda Pharmaceuticals America, Inc.
- NDC Codes
- 1
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- VELAGLUCERASE ALFA
Indications and Usage
1 INDICATIONS AND USAGE VPRIV is indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease. VPRIV is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease. ( 1 )